Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22940100 | 0.84 | PGR (0.31) | — | |
| SCHEMBL26042568 | 0.78 | — | — | |
| SCHEMBL26421719 | 0.74 | CA12 (0.33) | — | |
| SCHEMBL26045938 | 0.74 | — | — | |
| SCHEMBL105108 | 0.73 | CYP1A2 (0.31) | CYP1A2MAPK1 | |
| SCHEMBL21042888 | 0.71 | CA12 (0.32) | — | |
| Ammonia Solution, Strong SCHEMBL27332852 | 0.70 | — | — | |
| SCHEMBL23950126 | 0.67 | PGR (0.31) | — | |
| SCHEMBL2478250 | 0.67 | CYP1A2 (0.31) | CYP1A2MAPK1 | |
| SCHEMBL19333378 | 0.67 | CYP1A2 (0.31) | CYP1A2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10934295-B2 | Antimicrobials and methods of making and using same | BioVersys AG (CH) | 2021-03-02 | — | — | US | disclosed |
| US-20190211018-A1 | ANTIMICROBIALS AND METHODS OF MAKING AND USING SAME | RIB-X PHARMACEUTICALS, INC. | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10934295-B2 | Antimicrobials and methods of making and using same | LPO, MPO, OAT | CYP1A2 1636/4885MAPK1 1808/4885 |
| US-20190211018-A1 | ANTIMICROBIALS AND METHODS OF MAKING AND USING SAME | LPO, MPO, OAT | CYP1A2 1636/4885MAPK1 1808/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.